Pharmaceuticals

Shares of Lannett Company (AMEX: LCI) have been trending higher in recent trading sessions as the company is expecting NDA approval from the FDA for its morphine sulfate oral solution with a re-launch anticipated in early 2011. During Monday's session, LCI has risen 2.02% to $5.32. Volume has been...

Dryships (NASDAQ: DRYS) and XOMA Limited (NASDAQ: XOMA) are on the naughty list today, but Repros Therapeutics Inc. (NASDAQ: RPRX) continues to be on the nice list, with shares gaining another 66% today. DryShips announced this morning it was going to buy 12 tankers for $770 million, and...

Shares of Watson Pharmaceuticals (NYSE: WPI) are higher on the session by 0.41%, currently trading at $51.88. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages. Options traders are buying calls on the name today...

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) continues to see buying interest, gaining almost 6% on back of news that a Phase 2 study of its drug, belinostat, reached its target enrollment. Here is the press release from last week in its entirety.

Biogen Idec (BIIB) and partner Elan Corporation (ELN) recently announced their intention to seek approval for updating the label of their multiple sclerosis therapy, Tysabri. Biogen and Elan have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration...

Biogen Idec (BIIB) and partner Elan Corporation (ELN) recently announced their intention to seek approval for updating the label of their multiple sclerosis therapy, Tysabri. Biogen and Elan have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration...

Repros Therapeutics Inc (NASDAQ: RPRX) jumped 37.96% to $3.54 by 10:00 am. RPRX has completed two animal model studies of the use of Proellex. Private Media Group Inc (NASDAQ: PRVT) shares surged 27.62% to $1.34. PRVT's shares have dipped 46.97% over the past 52 weeks, while the S&P 500 index...

Vivus, Inc. (VVUS) recently announced that it has filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) seeking approval for Qnexa. The company is looking to get Qnexa approved in the EU for the treatment of obesity (in conjunction with a mildly hypocaloric...

Vivus, Inc. (VVUS) recently announced that it has filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) seeking approval for Qnexa. The company is looking to get Qnexa approved in the EU for the treatment of obesity (in conjunction with a mildly hypocaloric...

Biogen Idec (BIIB) and partner Elan Corporation (ELN) recently announced their intention to seek approval for updating the label of their multiple sclerosis therapy, Tysabri. Biogen and Elan have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration...

Amarin Corporation plc (NASDAQ: AMRN) have had a strong month, gaining some 120%, without much volatility. Generally, when you see strong runs like this, there is some giveback and ebbs and flows to the name, but this has been a steady run, leading some to speculate whether one trader is cornering...

Biogen Idec (BIIB) and partner Elan Corporation (ELN) recently announced their intention to seek approval for updating the label of their multiple sclerosis therapy, Tysabri. Biogen and Elan have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration...

Biogen Idec (BIIB) and partner Elan Corporation (ELN) recently announced their intention to seek approval for updating the label of their multiple sclerosis therapy, Tysabri. Biogen and Elan have submitted a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration...